SEC Form 4 · accession 0001209191-15-044052
Clovis Oncology, Inc. · CLVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian G Atwood
Director
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 8:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 14, 2015 | J | 404,867 | $0.00 | D | 404,866 | I | See Footnote |
| Common StockF4 | May 14, 2015 | J | 91,279 | $0.00 | A | 91,279 | I | See Footnote |
| Common StockF4 | May 14, 2015 | J | 91,279 | $0.00 | D | 0 | I | See Footnote |
| Common StockF7 | May 14, 2015 | J | 2,550 | $0.00 | D | 2,550 | I | See Footnote |
| Common StockF8 | May 14, 2015 | J | 283 | $0.00 | A | 13,638 | I | See Footnote |
| Common StockF8 | May 14, 2015 | J | 6,729 | $0.00 | A | 20,367 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital IV, L.P. ("VVC IV") without consideration to its partners.
- F2The shares are held by VVC IV. In his capacity as a managing member of Versant Ventures IV, LLC ("VV IV"), which is the general partner of VVC IV, the Reporting Person shares voting and investment authority over the shares held by the VVC IV and may be deemed to beneficially own the shares. Pursuant to General Instruction 4(b)(iv) to Form 4, all of the shares held by VVC IV are reported herein, and the Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F3Represents a change in the form of ownership by virtue of the receipt of shares in the pro-rata distribution of Common Stock of the Issuer by VVC IV.
- F4The shares are held by VV IV. The Reporting Person shares voting and investment authority over the shares held by the VV IV and may be deemed to beneficially own the shares. Pursuant to General Instruction 4(b)(iv) to Form 4, all of the shares held by VV IV are reported herein, and the Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F5Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV IV without consideration to its members.
- F6Represents a pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by Versant Side Fund IV, L.P. ("VSF IV") to its partners.
- F7The shares are held by VSF IV. In his capacity as a managing member of VV IV, which is the general partner of VSF IV, the Reporting Person shares voting and investment authority over the shares held by the VSF IV and may be deemed to beneficially own the shares. Pursuant to General Instruction 4(b)(iv) to Form 4, all of the shares held by VSF IV are reported herein, and the Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F8The shares are held by the Atwood-Edminster Trust dated 4/2/2000 (the "Trust"). Brian G. Atwood (the "Reporting Person") is a trustee and a named beneficiary of the Trust. Pursuant to General Instruction 4(b)(iv) to Form 4, all of the shares held by the Trust are reported herein, and the Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.